Patterns of Failure in Multiple Myeloma with Extramedullary Disease Following Anti-BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy

被引:0
|
作者
Nakashima, J. Y. [1 ]
Khatri, V. [1 ]
Cruz-Chamorro, R. J. [1 ]
Zhou, J. [2 ]
Patra, P. [2 ]
Gonzalez, R. [3 ]
De Avila, G. [3 ]
Locke, F. L. [3 ]
Liu, H. D. [3 ]
Nishihori, T. [3 ]
Puglianini, O. C. [3 ]
Alsina, M. [3 ]
Garjales-Cruz, A. [4 ]
Baz, R. [4 ]
Shah, B. D. [4 ]
Shain, K. [4 ]
Jain, M. D. [3 ]
Hansen, D. [3 ]
Freeman, C. [3 ]
Figura, N. B. [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[2] Univ S Florida, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1121
引用
收藏
页码:S206 / S207
页数:2
相关论文
共 50 条
  • [21] Monitoring anti-BCMA CAR T-Cell Therapy with bb2121 in relapsed multiple myeloma
    Seipel, K.
    Wiedemann, G.
    Jeker, B.
    Porret, N.
    Taleghani, B. Mansouri
    Bacher, U.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2021, 151 : 24 - 24
  • [22] Biallelic Loss of BCMA Triggers Resistance to Anti-BCMA CAR T Cell Therapy in Multiple Myeloma
    Samur, Mehmet K.
    Fulciniti, Mariateresa
    Aktas-Samur, Anil
    Bazarbachi, Abdul Hamid
    Tai, Yu-Tzu
    Campbell, Timothy B.
    Petrocca, Fabio
    Hege, Kristen
    Kaiser, Shari
    Anderson, Kenneth
    Munshi, Nikhil C.
    BLOOD, 2020, 136
  • [23] Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
    Raje, Noopur
    Berdeja, Jesus
    Lin, Yi
    Siegel, David
    Jagannath, Sundar
    Madduri, Deepu
    Liedtke, Michaela
    Rosenblatt, Jacalyn
    Maus, Marcela V.
    Turka, Ashley
    Lam, Lyh-Ping
    Morgan, Richard A.
    Friedman, Kevin
    Massaro, Monica
    Wang, Julie
    Russotti, Greg
    Yang, Zhihong
    Campbell, Timothy
    Hege, Kristen
    Petrocca, Fabio
    Quigley, M. Travis
    Munshi, Nikhil
    Kochenderfer, James N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (18): : 1726 - 1737
  • [24] Anti-BCMA chimeric antigen receptor T-cell therapy in multiple myeloma: despite a strong efficacy, persistence of autologous T cells remains a major challenge
    Karlin, Lionel
    HEMATOLOGIE, 2021, 27 : 5 - 12
  • [25] Prophylaxis and Vaccinations for Infections with BCMA Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma: Usmirc Practice Patterns
    Kamboj, Ishita
    Snyder, Jordan
    Gorsline, Chelsea
    Ince, Dilek
    Majeed, Aneela
    Anwer, Faiz
    Shaikh, Hira
    Khan, Abdullah Mohammad
    Abdallah, Al-Ola
    Green, Kimberly M.
    Atrash, Shebli
    Tiger, Claire Yun Kyoung Ryu
    Mewawalla, Prerna
    Paul, Barry
    Ahmed, Nausheen
    BLOOD, 2024, 144 : 5040 - 5041
  • [26] OVERALL RESPONSE AND COMPLETE RESPONSE WITH ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM) : A SYSTEMATIC REVIEW AND META-ANALYSIS
    Aggarwal, S.
    Bela, A.
    Topaloglu, O.
    VALUE IN HEALTH, 2020, 23 : S25 - S25
  • [27] Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma
    Liang, Zhiyu
    Li, Ping
    Kang, Liqing
    Zhou, Lili
    Xu, Yang
    Ye, Shiguang
    Du, Juan
    Li, Bing
    Wang, Yiwen
    Yu, Lei
    Qian, Wenbin
    Liang, Aibin
    BLOOD ADVANCES, 2022, 6 (01) : 293 - 296
  • [28] Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma
    Wang, Ying
    Li, Chunrui
    Xia, Jieyun
    Li, Ping
    Cao, Jiang
    Pan, Bin
    Tan, Xu
    Li, Hujun
    Qi, Kunming
    Wang, Xiangmin
    Shi, Ming
    Jing, Guangjun
    Yan, Zhiling
    Cheng, Hai
    Zhu, Feng
    Sun, Haiying
    Sang, Wei
    Li, Depeng
    Zhang, Xi
    Li, Zhenyu
    Zheng, Junnian
    Liang, Aibin
    Zhou, Jianfeng
    Xu, Kailin
    BLOOD ADVANCES, 2021, 5 (23) : 5290 - 5299
  • [29] Patterns of Relapse and Clinical Outcomes in Multiple Myeloma Patients after Anti-BCMA CAR T-Cell Therapy: Implications for Patient's Monitoring after CAR T-Cell Therapy
    Puglianini, Omar Alexis Castaneda
    Peres, Lauren C.
    Hansen, Doris K.
    Nishihori, Taiga
    Grajales-Cruz, Ariel F.
    Blue, Brandon J.
    Brayer, Jason
    Freeman, Ciara L.
    Shain, Kenneth H.
    Liu, Hien D.
    Ochoa, Jose
    Locke, Frederick L.
    Baz, Rachid C.
    Alsina, Melissa
    BLOOD, 2022, 140 : 7538 - 7539
  • [30] Incidence of Parkinsonism As a Complication of Anti-BCMA CAR-T Cell Therapy in Multiple Myeloma
    Singh, Vaishnavi
    Master, Samip
    BLOOD, 2023, 142